ES2014527A6 - Procedimiento para la determinacion de virus sida. - Google Patents

Procedimiento para la determinacion de virus sida.

Info

Publication number
ES2014527A6
ES2014527A6 ES8801341A ES8801341A ES2014527A6 ES 2014527 A6 ES2014527 A6 ES 2014527A6 ES 8801341 A ES8801341 A ES 8801341A ES 8801341 A ES8801341 A ES 8801341A ES 2014527 A6 ES2014527 A6 ES 2014527A6
Authority
ES
Spain
Prior art keywords
polypeptides
antibodies against
aids virus
against aids
elicit antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8801341A
Other languages
English (en)
Inventor
Wilhelm Bannwarth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES2014527A6 publication Critical patent/ES2014527A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA DETERMINACION DE VIRUS SIDA UTILIZANDO ANTICUERPOS CONTRA UN NUEVO POLIPEPTIDO RECOMBINANTE. EL PROCEDIMIENTO SE CARACTERIZA PORQUE SE UTILIZAN ANTICUERPOS CONTRA UN POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDO REPRESENTADA POR LA FORMULA (I) O SUS FRAGMENTOS QUE PROPORCIONAN AN TICUERPOS FRENTE A VIRUS DE SIDA Y/O QUE REACCIONAN CON SIDA-ANTICUERPOS O POLIPEPTIDOS INMUNOLOGENICOS Y/O ANTIGENICOS RELATIVOS A CUALQUIERA DE LOS POLIPEPTIDOS PRECEDENTES MEDIANTE SUSTITUCION O SUSTITUCIONES DE AMINOACIDOS.
ES8801341A 1985-10-17 1988-04-29 Procedimiento para la determinacion de virus sida. Expired - Fee Related ES2014527A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525615A GB8525615D0 (en) 1985-10-17 1985-10-17 Polypeptides

Publications (1)

Publication Number Publication Date
ES2014527A6 true ES2014527A6 (es) 1990-07-16

Family

ID=10586812

Family Applications (7)

Application Number Title Priority Date Filing Date
ES8602630A Expired ES2009210A6 (es) 1985-10-17 1986-10-16 Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
ES8801340A Expired ES2006925A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de vectores de expresion.
ES8801342A Expired ES2010538A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de un gen sintetico.
ES8801339A Expired ES2009907A6 (es) 1985-10-17 1988-04-29 Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
ES8801337A Expired ES2009905A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de anticuerpos frente a virus de sida.
ES8801338A Expired ES2009906A6 (es) 1985-10-17 1988-04-29 Procedimiento de preparacion de transformantes bacterianos.
ES8801341A Expired - Fee Related ES2014527A6 (es) 1985-10-17 1988-04-29 Procedimiento para la determinacion de virus sida.

Family Applications Before (6)

Application Number Title Priority Date Filing Date
ES8602630A Expired ES2009210A6 (es) 1985-10-17 1986-10-16 Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
ES8801340A Expired ES2006925A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de vectores de expresion.
ES8801342A Expired ES2010538A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de un gen sintetico.
ES8801339A Expired ES2009907A6 (es) 1985-10-17 1988-04-29 Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
ES8801337A Expired ES2009905A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de anticuerpos frente a virus de sida.
ES8801338A Expired ES2009906A6 (es) 1985-10-17 1988-04-29 Procedimiento de preparacion de transformantes bacterianos.

Country Status (11)

Country Link
EP (1) EP0219106A3 (es)
JP (1) JPS6299398A (es)
AU (1) AU602315B2 (es)
BR (1) BR8605053A (es)
DK (1) DK496486A (es)
ES (7) ES2009210A6 (es)
GB (1) GB8525615D0 (es)
IL (1) IL80304A0 (es)
NO (1) NO864139L (es)
NZ (1) NZ217895A (es)
ZA (1) ZA867748B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
US6218102B1 (en) * 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
SE8802176D0 (sv) * 1988-06-10 1988-06-10 Kabigen Ab Fusion protein and its use
AU629237B2 (en) * 1988-08-30 1992-10-01 Applied Research Systems Ars Holding N.V. Recombinant fusion proteins for altering hormone secretion
DE68921034D1 (de) * 1988-09-27 1995-03-23 Dana Farber Cancer Inst Inc Vektor, der ein replikationskompetentes HIV-I-Provirus und ein heterologes Gen enthält.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
EP0645454A3 (en) * 1993-06-22 1997-01-15 Vladimir Glebovich Lunin Protein containing a chimeric somatostatin, coding DNA, immunogenic compositions, and method for improving the productivity of farmes animals.
IT1271486B (it) * 1993-10-12 1997-05-28 Italfarmaco Spa Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
EP0993615A1 (en) * 1998-03-04 2000-04-19 Universal Healthwatch, Inc. Rapid confirmatory test for microbial infections
ATE508139T1 (de) * 2003-04-11 2011-05-15 Pasteur Institut Synthetische peptid-hiv-vakzine: das cbd-epitop als effizientes immunogen zur induktion hiv- neutralisierender antikörper
CN106434833A (zh) 2004-05-23 2017-02-22 杰勒德·M·豪斯 Theramutein调节剂
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
DE3588248T2 (de) * 1984-10-18 2004-07-01 Institut Pasteur LAV-Antigene und -Peptide
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.

Also Published As

Publication number Publication date
DK496486D0 (da) 1986-10-16
IL80304A0 (en) 1987-01-30
ES2009210A6 (es) 1989-09-16
BR8605053A (pt) 1987-07-14
EP0219106A2 (en) 1987-04-22
NO864139L (no) 1987-04-21
ES2009905A6 (es) 1989-10-16
AU6399786A (en) 1987-04-30
DK496486A (da) 1987-04-18
JPS6299398A (ja) 1987-05-08
EP0219106A3 (en) 1989-02-08
ES2009907A6 (es) 1989-10-16
ES2006925A6 (es) 1989-05-16
AU602315B2 (en) 1990-10-11
ZA867748B (en) 1987-07-29
NO864139D0 (no) 1986-10-16
ES2010538A6 (es) 1989-11-16
ES2009906A6 (es) 1989-10-16
NZ217895A (en) 1991-05-28
GB8525615D0 (en) 1985-11-20

Similar Documents

Publication Publication Date Title
ES2009210A6 (es) Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
GB8610600D0 (en) Transformation of trichoderma
MY121185A (en) Recombinant antibodies for human therapy.
PT76546A (en) Process for preparing functional human urokinase protein
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
OA08947A (en) Mammalian interleukin-4.
ES8800359A1 (es) Metodo de produccion de factor viii:c humano
UA27706C2 (uk) Спосіб одержання гетерологічного поліпептиду
PT79917A (en) Process for preparing new renin- inhibotory peptides and their use
IE801137L (en) Dna transfer vector
EP0209543A4 (en) FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE.
MY103362A (en) Production of proteins in active forms
NO180181C (no) Fremgangsmåte for fremstilling av et is-kjernedannende protein, plasmider og bakteriestammer
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
EP0149241A3 (en) Dna base sequence containing regions involved in the production and secretion of a protein, recombinant dna including the whole or a part of the dna base sequence, and method of producing proteins by use of the recombinant dna
AU582416B2 (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms
IL89391A0 (en) Structural gene coding for an insecticidal endotoxin protein,said protein,its production and use of said gene and protein
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
EP0166458A3 (en) Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
ES8800342A1 (es) Procedimiento para preparar un vector de levadura de copias multiples,estables y recombinante
ZA877902B (en) Yeast expression vectors for ifn-omega,processes for preparing them and their use
ES8609301A1 (es) Procedimiento para la obtencion de 3-metil-7-fluor-5-nitro- benzotiofeno
IL71559A0 (en) Novel strain of trichoderma harzianum,its isolation and cultivation,peptides and other compounds produced thereby and their use in plant-disease control
IL104845A0 (en) Method for the transformation of cotton,vectors used in the above method and cotton obtained by the above method

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009